Recombinant plasminogen activator inhibitor-1 inhibits intimal hyperplasia. - Wikidata - wikimedia - TriplyDB

Recombinant plasminogen activator inhibitor-1 inhibits intimal hyperplasia.

Recombinant plasminogen activator inhibitor-1 inhibits intimal hyperplasia.

http://www.wikidata.org/entity/Q42166965

about

Vitronectin-binding PAI-1 protects against the development of cardiac fibrosis through interaction with fibroblasts Plasminogen activator inhibitor-1 suppresses profibrotic responses in fibroblasts from fibrotic lungs Inhibition of NF-κB prevents high glucose-induced proliferation and plasminogen activator inhibitor-1 expression in vascular smooth muscle cells.Effects of plasminogen activator inhibitor-1-specific RNA aptamers on cell adhesion, motility, and tube formation.Vitronectin inhibits neutrophil apoptosis through activation of integrin-associated signaling pathways Platelets: Context-Dependent Vascular Protectors or Mediators of Disease.PAI-1 Inhibition - Another Therapeutic Option for Cardiovascular Protection.Therapeutic potential of plasminogen activator inhibitor-1 inhibitors.Restenosis after PCI. Part 1: pathophysiology and risk factors.Gene expression profile in human skeletal muscle cells infected with human adenovirus type 36.Altered phenotypic gene expression of 10T1/2 mesenchymal cells in nonuniformly stretched PEGDA hydrogels.Resolution of Skin Fibrosis by Neutralization of the Antifibrinolytic Function of Plasminogen Activator Inhibitor 1.The role of urokinase plasminogen activator and plasmin activator inhibitor-1 on vein wall remodeling in experimental deep vein thrombosis.A novel agent with histone deacetylase inhibitory activity attenuates neointimal hyperplasia.

P2860

Q35180538-9339470C-031E-4DD9-9EA4-131FAEDF15AD Q35351530-C021AAB0-F8FA-48E3-8AE9-FC2807517460 Q35667264-0EF2356A-3CB6-4124-B8CA-E4E1A5983781 Q35757741-4470DDFB-FEC8-49DA-8731-7297D851C18D Q36049729-4FD5F262-9912-4847-BF00-7F034F11C4A4 Q37007335-C8FF8114-CA7A-4CFE-A5F3-2C0958342C9D Q37668960-A382F585-44F8-43EB-B9BC-72514E3423AE Q37775818-24F1FA94-08F9-454C-ACCF-9C782438D20F Q37930965-EBF34E57-05AE-4E77-BCBF-7B9682A5AFA2 Q38411386-55675584-FFF7-4B7C-B33E-3DEA114428C7 Q39154689-03B6A918-1CC8-42F2-A5C2-F39D81EC5817 Q40491370-4BA27BC4-CA38-4D36-931E-AFC1C2FD7B98 Q41892701-02AC868A-0303-43D5-967D-89633D31A39D Q53036160-0717DDEB-5F64-4C64-93E4-B4031D033690

P2860

Recombinant plasminogen activator inhibitor-1 inhibits intimal hyperplasia.

http://www.wikidata.org/entity/Q42166965

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

Recombinant plasminogen activator inhibitor-1 inhibits intimal hyperplasia.

@en

Recombinant plasminogen activator inhibitor-1 inhibits intimal hyperplasia.

@nl

type

label

Recombinant plasminogen activator inhibitor-1 inhibits intimal hyperplasia.

@en

Recombinant plasminogen activator inhibitor-1 inhibits intimal hyperplasia.

@nl

prefLabel

Recombinant plasminogen activator inhibitor-1 inhibits intimal hyperplasia.

@en

Recombinant plasminogen activator inhibitor-1 inhibits intimal hyperplasia.

@nl

P1433

Q42166965-A1B470DC-9EAA-4558-97A4-AD1C9CC7B464

P1476

Q42166965-F5331D78-51DE-4F1E-86AB-72E56D954658

P2093

Q42166965-385833F7-326E-4FB2-B97F-1C5D5652F877

Q42166965-3D17E7AF-E765-49AF-94A1-6C5277C7A299

Q42166965-6581528C-39BE-48F5-A051-5D60530AD149

Q42166965-D5DD934B-5A88-49FA-AD8A-4DEA7B2C02DA

P2860

Q42166965-297F5F45-F1F4-40DA-AE04-F7B8D4747D12

Q42166965-2E39644D-66C4-4911-9A5A-C906A1C8688D

Q42166965-2EAF2CA1-50BD-4B9E-B257-E627FC63440A

Q42166965-359EFADA-B706-471B-BDB1-84D41BA8038C

Q42166965-371AB240-2830-4E7F-BB2D-A00831CB6482

Q42166965-3EBA1480-C872-462D-803A-157A433EC7BA

Q42166965-4943CBA9-D50C-4A13-B377-CAC7081B8B11

Q42166965-60601525-92C7-412E-B932-236AA83ECC6A

Q42166965-616AAE20-43C3-48E8-B470-147BB961F60A

Q42166965-61A73A5B-2A35-46CD-8C16-B6105F8A63C4

P304

Q42166965-27A71CB8-1956-44AD-83AF-5A86DFF99F52

P31

Q42166965-A4961F9C-EB3C-40A7-9786-4060181E0657

P356

Q42166965-95240007-CA5B-4CCB-98C2-447B95D819FD

P407

Q42166965-16103158-9A57-40C2-8B35-70D12FA04E29

P433

Q42166965-A0355D18-1B00-414E-AFF6-66DA23D75C0A

P478

Q42166965-0A2FD1BE-3387-4496-8FCC-13EF7E33C37F

P50

Q42166965-7C3560E0-0AE3-4738-BC11-093E406B6A17

P577

Q42166965-24AD86A5-553E-4E06-8007-6CE96C9FA750

P5875

Q42166965-EFA13688-3189-4A93-91F4-8AABADD926AF

P698

Q42166965-1641E615-6727-43D8-B6F1-80030C835AF8

P932

Q42166965-EF493FDB-442C-4CA4-8A59-9DC1998AD288

P356

ATVBAHA.109.189514

P1433

Arteriosclerosis, Thrombosis, and Vascular Biology

P1476

Recombinant plasminogen activator inhibitor-1 inhibits intimal hyperplasia.

@en

P2093

Grainne A McMahon

http://www.w3.org/2001/XMLSchema#string

Jianbo Wu

http://www.w3.org/2001/XMLSchema#string

Lin Peng

http://www.w3.org/2001/XMLSchema#string

William P Fay

http://www.w3.org/2001/XMLSchema#string

P2860

Induction of apoptosis in vascular cells by plasminogen activator inhibitor-1 and high molecular weight kininogen correlates with their anti-adhesive properties

Alteration of serpin specificity by a protein cofactor. Vitronectin endows plasminogen activator inhibitor 1 with thrombin inhibitory properties

Inhibitory role of plasminogen activator inhibitor-1 in arterial wound healing and neointima formation: a gene targeting and gene transfer study in mice

The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin

Remodeling of the vessel wall after copper-induced injury is highly attenuated in mice with a total deficiency of plasminogen activator inhibitor-1

Plasminogen activator inhibitor type 1 is increased in the arterial wall of type II diabetic subjects.

Vitronectin is not essential for normal mammalian development and fertility.

Old dogs and new tricks: proteases, inhibitors, and cell migration.

Unexpected role of plasminogen activator inhibitor 1 in cell adhesion and detachment.

Plasminogen activator inhibitor-1 detaches cells from extracellular matrices by inactivating integrins.

P304

1565-1570

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/ATVBAHA.109.189514

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P50

Daniel A. Lawrence

P577

2009-07-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26338065

http://www.w3.org/2001/XMLSchema#string

P698

19574558

http://www.w3.org/2001/XMLSchema#string

P932

2771380

http://www.w3.org/2001/XMLSchema#string